QMSMEDI Share Price Target 2030

CAGR-based price projection for QMS Medical Allied Services Limited (QMSMEDI) targeting 2030, derived from official NSE exchange closing prices.

Bear Case (14.3% CAGR)
Rs 236
2030 Target
Base Case (35.8% CAGR)
Rs 469
2030 Target
Bull Case (109.6% CAGR)
Rs 2,665
2030 Target

Current Market Snapshot

CMP: Rs 138.13
52W High: Rs 138.13
52W Low: Rs 100.25
1Y CAGR: 84.3%
3Y CAGR: 35.8%

Year-by-Year Price Projection

YearBear CaseBase CaseBull Case
2027 Rs 158 Rs 188 Rs 289
2028 Rs 180 Rs 255 Rs 607
2029 Rs 206 Rs 346 Rs 1,272
2030 Rs 236 Rs 469 Rs 2,665

Other QMSMEDI Price Targets

2025 2026 2027 2028 2035 2040 2050

Frequently Asked Questions

What is the QMSMEDI share price target for 2030?

Based on historical growth analysis, the QMSMEDI share price target for 2030 ranges from Rs 236 (conservative) to Rs 469 (base case) to Rs 2,665 (optimistic). These projections are based on trailing CAGR and should not be treated as guaranteed outcomes.

What is the current share price of QMSMEDI?

The current market price of QMSMEDI (QMS Medical Allied Services Limited) is Rs 138.13. The 52-week high is Rs 138.13 and 52-week low is Rs 100.25.

Is QMSMEDI a good stock to buy for the long term?

Long-term investment decisions depend on individual risk tolerance, financial goals, and portfolio diversification. Examine the company's fundamentals, debt-to-equity ratio, promoter holding, and competitive positioning within its sector. BrokerLens provides data-driven analysis; consult a SEBI-registered financial advisor before investing.

What methodology does BrokerLens use for QMSMEDI price targets?

BrokerLens computes price targets using historical Compound Annual Growth Rate (CAGR) derived from official NSE closing prices. Three scenarios are modeled: Bear (conservative at 14.3% CAGR), Base (35.8% CAGR), and Bull (optimistic at 109.6% CAGR). These are statistical projections, not guaranteed forecasts.

Disclaimer: Share price targets on BrokerLens are statistical CAGR projections based on historical NSE closing prices. They are NOT guaranteed outcomes, investment advice, or analyst recommendations. Past performance does not guarantee future results. Consult a SEBI-registered investment advisor before making investment decisions. Mutual fund and equity investments are subject to market risks.